.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Chubb
Cipla
Express Scripts
AstraZeneca
Fish and Richardson
Cerilliant
UBS
Healthtrust

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040368

« Back to Dashboard
NDA 040368 describes ORPHENADRINE CITRATE, which is a drug marketed by Watson Labs, Sandoz, Tedor Pharma Inc, Invagen Pharms, West-ward Pharms Int, Ascot, Impax Pharms, Akorn, Gavis Pharms, Sagent Pharms, and Stevens J, and is included in fifteen NDAs. It is available from thirty suppliers. Additional details are available on the ORPHENADRINE CITRATE profile page.

The generic ingredient in ORPHENADRINE CITRATE is aspirin; caffeine; orphenadrine citrate. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.

Summary for NDA: 040368

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details

Pharmacology for NDA: 040368

Suppliers and Packaging for NDA: 040368

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL 040368 ANDA Impax Generics 0115-2011 0115-2011-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-2011-01)
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL 040368 ANDA Impax Generics 0115-2011 0115-2011-02 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-2011-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength100MG
Approval Date:Jun 23, 2000TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Accenture
US Army
Fuji
Mallinckrodt
Covington
Colorcon
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot